| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0003 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0007 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |